Dergiler / Namık Kemal Tıp Dergisi / 2019 / Cilt: 7 - Sayı: 3

A STUDY ON THE EFFECTS OF DIRECT FACTOR XA INHIBITORS AND DIRECT THROMBIN INHIBITORS ON HUMAN PRIMARY CHONDROCYTE CULTURES

Direkt Faktör Xa İnhibitörleri ve Direkt Trombin İnhibitörlerinin İnsan Primer Kondrosit Kültürlerine Etkileri Üzerine Bir Çalışma

Sayfa
201–208
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, clinicians should know that drugs used for the prevention or treatment of diseases may suppress chondrocyte proliferation and damage the extracellular matrix formation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim:This study investigates the effects of two direct factor Xa inhibitors, apixaban and rivaroxaban, and a direct thrombin inhibitor, dabigatran, on human primary chondrocytecultures.
📊
Temel Bulgular & Veri:Cell viability and the toxicity of drugs were evaluated using a commercial assay kit, and the results were confirmed using two nucleic acid binding dyes, acridine orange and propidium iodide.
💡
Sonuç & Katkı:However, clinicians should know that drugs used for the prevention or treatment of diseases may suppress chondrocyte proliferation and damage the extracellular matrix formation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim:This study investigates the effects of two direct factor Xa inhibitors, apixaban and rivaroxaban, and a direct thrombin inhibitor, dabigatran, on human primary chondrocytecultures. Materials and Methods:Monolayer cultured chondrocytes were prepared. Cell cultures were treated with dabigatran, apixaban, and rivaroxaban. Cultures without drug treatments served as the control group. Using an inverted light microscope, the cell surface morphology was examined. Cell viability and the toxicity of drugs were evaluated using a commercial assay kit, and the results were confirmed using two nucleic acid binding dyes, acridine orange and propidium iodide. The expressions of cartilage oligomeric protein, matrix metalloproteinase-7, and matrix metalloproteinase-19 were assessed using the real-time polymerase chain reaction analysis. All the analyses were performed within 21 days. The data obtained were statistically evaluated. Results:The administration of the three drugs changed the cell viability, proliferation, and expressions of cartilage oligomeric protein, matrix metalloproteinase-7, and matrix metalloproteinase- 19. The results were statistically significant (P<0.05). Conclusion:Results obtained from in vitro studies may not provide accurate and reliable insight for clinical practices. However, clinicians should know that drugs used for the prevention or treatment of diseases may suppress chondrocyte proliferation and damage the extracellular matrix formation.

Abstract

Amaç:Bu çalışmada; direk faktör Xa inhibitörü apiksaban ve rivaroxaban ile Direk/selektif olarak thrombin inhibitörü olan dabigatranın, primer insan kıkırdak hücre kültürleri üzerine etkisinin gözlenmesi amaçlandı. Materyal ve Metot:Kondrosit kültürleri monolayer olarak çoğaltılldı. Bu kültürler üzerine apiksaban, dabigatran ve rivaroksaban farmasötik ajanları ilave edildi. İlaç uygulanmayan hücre kültürleri kontrol grubu olarak kullanıldı. Hücrelere ait yüzey morfolojisi invert ışık mikroskobisi ile değerlendirildi. Hücrelerin sağlıklı olup olmadığı ve proliferasyonlarının devam edip etmediği MTT analizi ile spektrofotometrik olarak belirlendi ayrıca AO/PI fluresan boyamalardan da yararlanılarak apoptotik hücre ölümü varlığı araştırıldı. Kıkırdak oligo matriks protein (COMP), matriks metalloproteinaz (MMP)-7 ve MMP-19 genlerine ait ifadeler ise quantitative real time polymerase chain reaction (qRT-PCR) ile test edildi. Tüm analizler 21 gün içinde gerçekleştirildi. Elde edilen veriler istatistiksel olarak değerlendirildi ve sonuçlarraporlandı. Bulgular:Bu üç farmakolojik ajanın, hem hücre canlılığı ve proliferasyonunu hem de COMP, MMP-7 ve MMP-19 genlerine ait ifadeleri değiştirdiği ve bu sonuçların istatistiksel olarak anlamlı olduğu kaydedildi (P<0.05). Sonuç:Her ne kadar in-vitro deneylerden elde edilen sonuçlar klinik uygulamaları tam olarak yansıtmıyor olsa bile, herhangi bir hastalığı önleyebilmek amacı ile uygulanan ilaçların, kondrosit proliferasyonunu baskılayabileceği ve/veya ekstraselüler matrix (ECM) yapısına zarar verebileceği gerçeği akıllardatutulmalıdır.

🔖

Bu Makaleye Atıf Yap

KAYA, Y. E., AKALAN, H., YILMAZ, İ., KARAARSLAN, N., ŞİRİN, D. Y., ÖZBEK, H., ATEŞ, Ö. (2019). A STUDY ON THE EFFECTS OF DIRECT FACTOR XA INHIBITORS AND DIRECT THROMBIN INHIBITORS ON HUMAN PRIMARY CHONDROCYTE CULTURES. Namık Kemal Tıp Dergisi, Cilt: 7 - Sayı: 3, 201–208. https://ajindex.com/articles/289068

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ozer N. Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case inlight of the clinical studies? Turk Kardiyol Dern Ars. 2016;44 Suppl 2:33-40
  2. Deveci OS, Demir M, Aksoy M. Use of dabigatran in patients with non-valvular atrial fibrillation: answers to frequently asked questions. Arch Turk Soc Cardiol. 2013;41 Suppl 4:25-33
  3. Bas DF, Topcuoglu MA, Arsava EM. Atrial fibrillation and stroke in the perspective of new oral anticoagulants. Turkish Journal of Cerebrovascular Diseases.2013;19(2):35-45
  4. Kaplan N, Karaarslan N, Yilmaz I, Sirin DY, Akgun FS, Caliskan T, et al. Are intervertebral disc tissue cells damaged when attempting to prevent thrombus formation using dabigatran, a new oral anticoagulant? Turk Neurosurg. 2019;29(4):470-477
  5. Coleman CI, Peacock WF, Bunz TJ, Alberts MJ. Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and previous stroke or transient ischemic attack. Stroke. 2017;48(8):2142- 2149
  6. Torrejon Torres R, Saunders R, Ho KM. A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia. J Orthop Surg Res.2019;14(1):93
  7. Isyar M, Yilmaz I, Yasar Sirin D, Yalcin S, Guler O, Mahirogullari M. A practical way to prepare primer human chondrocyte culture. J Orthop. 2016;13(3):162-7
  8. Gumustas SA, Yilmaz I, Isyar M, Sirin DY, Batmaz AG, Ugras AA, et al. Assessing the negative impact of phenyl alkanoic acid derivative, a frequently prescribed drug for the suppression of pain and inflammation, on the differentiation and proliferation of chondrocytes. J Orthop Surg Res.2016;11(1):70
  9. Guzelant AY, Isyar M, Yilmaz I, Sirin DY, Cakmak S, Mahirogullari M. Are chondrocytes damaged when rheumatologic inflammation is suppressed? Drug Chem Toxicol.2017;40(1):13-23
  10. Gumustas F, Yilmaz I, Sirin DY, Gumustas SA, Batmaz AG, Isyar M, et al. Chondrocyte proliferation, viability and differentiation is declined following administration of methylphenidate utilized for the treatment of attention-deficit/hyperactivity disorder. Hum Exp Toxicol.2017;36(9):981-992
  11. Dogan M, Isyar M, Yilmaz I, Bilir B, Sirin DY, Cakmak S, et al. Are the leading drugs against Staphylococcus aureus really toxic to cartilage? J Infect Public Health.2016;9(3):251-258
  12. Karaarslan N, Yilmaz I, Sirin DY, Ozbek H, Kaya YE, Aky